Nitika Sharma

Nitika Sharma

Cancer Treatment Centers of America - / United States
Others
AD Scientific Index ID: 5514080
person_outline Nitika Sharma's MOST POPULAR ARTICLES
1-) Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockadeCRG Stroud, A Hegde, C Cherry, AR Naqash, N Sharma, S Addepalli, ...Journal of Oncology Pharmacy Practice 25 (3), 551-557, 20192752019
2-) Malignant pleural effusion and cancer of unknown primary site: a review of literatureSF Awadallah, MR Bowling, N Sharma, A MohanAnnals of translational medicine 7 (15), 2019302019
3-) Antibiotic use and overall survival in lung cancer patients receiving nivolumab.TP Do, AM Hegde, CR Cherry, CRG Stroud, N Sharma, SD Cherukuri, ...Journal of Clinical Oncology 36 (15_suppl), e15109-e15109, 2018232018
4-) Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or AfterS Woody, A Hegde, H Arastu, MS Peach, N Sharma, P Walker, AW JuFrontiers in Oncology 12, 2022132022
5-) Outcomes of immunomodulatory radiation strategies in combination with nivolumab compared with single agent nivolumab in lung cancer patients.AM Hegde, CR Cherry, CRG Stroud, R Pinnamaneni, SD Cherukuri, ...Journal of Clinical Oncology 36 (15_suppl), e21134-e21134, 201882018